Abstract:The persistence of associative memories linked to the rewarding properties of drugs of abuse is a core underlying feature of the addiction process. Opiate class drugs in particular, possess potent euphorigenic effects which, when linked to environmental cues, can produce drug-related "trigger" memories that may persist for lengthy periods of time, even during abstinence, in both humans, and other animals. Furthermore, the transitional switch from the drug-naïve, non-dependent state to states of dependence and withdrawal, represents a critical boundary between distinct neuronal and molecular substrates associated with opiate-reward memory formation. Identifying the functional molecular and neuronal mechanisms related to the acquisition, consolidation, recall, and extinction phases of opiate-related reward memories is critical for understanding, and potentially reversing, addiction-related memory plasticity characteristic of compulsive drug-seeking behaviors. The mammalian prefrontal cortex (PFC) and basolateral nucleus of the amygdala (BLA) share important functional and anatomical connections that are involved importantly in the processing of associative memories linked to drug reward. In addition, both regions share interconnections with the mesolimbic pathway's ventral tegmental area (VTA) and nucleus accumbens (NAc) and can modulate dopamine (DA) transmission and neuronal activity associated with drug-related DAergic signaling dynamics. In this review, we will summarize research from both human and animal modeling studies highlighting the importance of neuronal and molecular plasticity mechanisms within this circuitry during critical phases of opiate addiction-related learning and memory processing. Specifically, we will focus on two molecular signaling pathways known to be involved in both drug-related neuroadaptations and in memory-related plasticity mechanisms; the extracellular-signal-regulated kinase system (ERK) and the Ca(2+)/calmodulin-dependent protein kinases (CaMK). Evidence will be reviewed that points to the importance of critical molecular memory switches within the mammalian brain that might mediate the neuropathological adaptations resulting from chronic opiate exposure, dependence, and withdrawal.

Caenorhabditis elegans for opioid addiction research

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Using <i>C</i>. <i>elegans</i> Genetics to Identify Regulators of -Opioid Receptor Signaling

Oxycodone Withdrawal Induces HDAC1/HDAC2-dependent Transcriptional Maladaptations in the Reward Pathway in a Mouse Model of Peripheral Nerve Injury

Genetic Behavioral Screen Identifies an Orphan Anti-Opioid System.

Food preference-based screening method for identification of effectors of substance use disorders using Caenorhabditis elegans

Study on psychoactive substances addiction in psychopharmacological profiles

Nicotine Motivated Behavior in C. elegans

An emerging multi-omic understanding of the genetics of opioid addiction

Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation

Dentate gyrus μ-opioid receptor-mediated neurogenic processes are associated with alterations in morphine self-administration

A common limiter circuit for opioid choice and relapse identified in a rodent addiction model

Modulation of Nicotine-Associated Behaviour in Rats By μ-Opioid Signals from the Medial Prefrontal Cortex to the Nucleus Accumbens Shell

Genome-wide association study reveals multiple loci for nociception and opioid consumption behaviors associated with heroin vulnerability in outbred rats

Effects of the novel selective κ-opioid receptor agonist NP-5497-KA on morphine-induced reward-related behaviors

Establishing the Framework to Evaluate Negative Modulators of Mu Opioid Receptor Signaling in Cells

Modeling neurodegeneration in Caenorhabditis elegans

Caenorhabditis elegans neuropeptide NLP-27 enhances neurodegeneration and paralysis in an opioid-like manner during fungal infection

Multi-omic network analysis identifies dysregulated neurobiological pathways in opioid addiction

A novel dopamine D2 receptor-NR2B protein complex might contribute to morphine use disorders